BLATOPICALOINTMENT
Approved
Apr 1964
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ELASE-CHLOROMYCETIN is a topical ointment combining three active ingredients: chloramphenicol (a broad-spectrum antibiotic), desoxyribonuclease (an enzyme that breaks down DNA in necrotic tissue), and fibrinolysin (a fibrin-dissolving enzyme). This combination was designed to treat infected wounds and promote tissue debridement by simultaneously addressing bacterial infection and facilitating removal of dead tissue.
LOE Approaching
Product is in late-stage lifecycle with minimal commercial activity; brand teams are likely in maintenance or wind-down mode with reduced headcount and focus on portfolio transition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ELASE-CHLOROMYCETIN offers limited career growth potential given its legacy status and approaching loss of exclusivity; roles are primarily defensive and focused on compliance, supply continuity, and managed wind-down rather than innovation or expansion. Career progression typically leads away from this product toward newer, higher-growth therapeutic areas within Pfizer's portfolio.
Regulatory Affairs Specialist
Worked on ELASE-CHLOROMYCETIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.